Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MGN-1601 enters phase I/II study in advanced renal cancer

Dec. 16, 2010

MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma

Dec. 16, 2010

Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer

Dec. 16, 2010

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment

Dec. 15, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Lilly suspends phase III trial of tasisulam in metastatic melanoma

Dec. 15, 2010

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Dec. 15, 2010

Zealand Pharma receives milestone payment from Helsinn Healthcare regarding ZP-1846

Dec. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...